Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
EIF4E2 Antibody, 4E-LP Antibody, 4EHP Antibody, EIF4E-like cap-binding protein Antibody, EIF-4E type 2 Antibody, EIF4EL3 Antibody, MRNA cap-binding protein 4EHP Antibody, EIF4E type 2 Antibody, EIF4E-like protein 4E-LP Antibody, IF4e Antibody
Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures.
Formalin-fixed and paraffin-embedded human breast carcinoma reacted with EIF4E2 Antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
Western blot of EIF4E2 Antibody in NCI-H460 cell line lysates (35 ug/lane). EIF4E2 (arrow) was detected using the purified antibody.
Western blot of EIF4E2 (arrow) using rabbit polyclonal EIF4E2 Antibody. 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the EIF4E2 gene.
Requested From: United States
Date Requested: 2/27/2017